BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5334474)

  • 1. [On high-dosage parenteral niamid treatment of depressive syndromes].
    Cornu F; Hodel J
    Nervenarzt; 1965 Dec; 36(12):515-8. PubMed ID: 5334474
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramuscular nialamide in intractable depression.
    Benady DR; Clein LJ; Pare CM
    Dis Nerv Syst; 1965 Dec; 26(12):792-4. PubMed ID: 5321917
    [No Abstract]   [Full Text] [Related]  

  • 3. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of depression with chlorimipramine (Anafranil)].
    Jovanović UJ; Sattes H
    Med Klin; 1970 Feb; 65(6):260-3. PubMed ID: 5519056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of the oral and injectable forms of a new antidepressive agent (doxepine) in 40 patients].
    Sichel JP; Baldauf A; Fonlupt V; Poupier G
    Ann Med Psychol (Paris); 1972; 2(2):272-81. PubMed ID: 4404814
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of parenteral nialamide in the treatment of reactive or neurotic depressive states].
    Cormary M
    Lyon Med; 1966 Apr; 215(15):1051-62. PubMed ID: 5930244
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chlorimipramine therapy of depressive with special analysis of blood pressure changes during infusions].
    Ose E
    Arzneimittelforschung; 1973 Jun; 23(6):817-23. PubMed ID: 4579950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary observations on the use of a new drug (Anafranil) in the treatment of depressive states].
    Fasanaro G; Scoleri G; Stella L; Vincitorio A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Oct; 95(5):930-7. PubMed ID: 5159722
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
    Fazio C; Andreoli V; Agnoli A; Casacchia M; Cerbo R
    Minerva Med; 1973 Apr; 64(29):1515-29. PubMed ID: 4576704
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled study of desipramine in the treatment of hospitalized depressive disorders.
    Vestre ND; Janecek J; Zimmermann R
    Int J Neuropsychiatry; 1967 Aug; 3(4):354-9. PubMed ID: 4863508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary report on the terapeutic activity and clinical as well as biological tolerance of endovenous 34.276 Ba in melancholias and depressive conditions].
    Volmat R; Allers G; Vittouris N; Dufoy F
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 113(2):410-5. PubMed ID: 4776681
    [No Abstract]   [Full Text] [Related]  

  • 12. [New therapeutic possibilities in depression: 5-hydroxytryptophan].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias ML
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):151-62. PubMed ID: 1099879
    [No Abstract]   [Full Text] [Related]  

  • 13. Note on the treatment of depression.
    Denber HC
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:141-5. PubMed ID: 5328013
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of depressive conditions using nialamide infusions].
    Misurec J; Bojanovský J; Chloupková K
    Cesk Psychiatr; 1966 Apr; 62(2):114-8. PubMed ID: 5930847
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of depressive states with infusions of Nialamide.
    Misurec J; Bojanovský J; Chloupková K
    Act Nerv Super (Praha); 1965 Aug; 7(3):294-5. PubMed ID: 5883125
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monochlorimipramine in depressive syndromes. Report of our therapeutic experiences, with special reference to the intravenous administration].
    Benassi P; Catalano A
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Oct; 95(5):919-29. PubMed ID: 5159721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chlorimipramine as the major treatment of depressive states (103 cases treated with intravenous perfusion)].
    Maillet-Jurquet A; Rance AM; Tollinchi G; Rance A; Roger J
    Encephale; 1970; 59(2):180-8. PubMed ID: 5458712
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with desipramine in endogenous and involutional depressions].
    Rodová A; Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):65-6. PubMed ID: 4907396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report of experiences with high dosage Hydiphen infusion treatment of depressive syndromes].
    Dreves B; Manthey I; Schmieter K; Haiduk A
    Psychiatr Neurol Med Psychol (Leipz); 1984 Feb; 36(2):95-100. PubMed ID: 6718599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.